BC-09-XQ45_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, (R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, VEGFR-2 (FLK-1/KDR) Inhibitors;erbB1) Inhibitors;EGFR (HER1;HER2 (erbB2) Inhibitors;Inhibitors of Signal Transduction Pathways;Angiogenesis Inhibitors targeting EGFR, ERBB2 (Novartis, 10297043)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10297043
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the BC-09-XQ45_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
GAPDH glyceraldehyde-3-phosphate dehydrogenase 3.05624
TMSB10 thymosin beta 10 2.27598
PPIH peptidylprolyl isomerase H (cyclophilin H) 1.70165
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.52696
OAZ1 ornithine decarboxylase antizyme 1 0.422724
CDC20 cell division cycle 20 0.410758
VPS4A vacuolar protein sorting 4 homolog A (S. cerevisiae) 0.297875
RPS18 ribosomal protein S18 0.297875
RPS16 ribosomal protein S16 0.254036
ENAM enamelin 0.220801
RPS2 ribosomal protein S2 0.211789

decreased expression

Symbol Name Standardized Value
CAMK2G calcium/calmodulin-dependent protein kinase II gamma -0.24014
EMC3 ER membrane protein complex subunit 3 -0.233106